Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
AdvanSix
ASIX
$460M
| $2.29M | ﹤0.01% |
68,632
-121,712
| -64% | -$5.43M |
|
|
HSII
5177
DELISTED
Heidrick & Struggles
HSII
| $2.29M | ﹤0.01% |
+70,930
| New | +$2.44M |
|
5178
PUT
Radian Group
RDN
$4.98B
| $2.29M | ﹤0.01% |
116,700
-14,600
| -11% | -$307K |
|
5179
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.3M
| $2.29M | ﹤0.01% |
39,776
-7,061
| -15% | -$425K |
|
5180
PUT
ProShares UltraPro Russell2000
URTY
$364M
| $2.29M | ﹤0.01% |
58,500
+10,200
| +21% | +$544K |
|
5181
CALL
iShares Russell 1000 ETF
IWB
$50B
| $2.29M | ﹤0.01% |
11,000
-5,800
| -35% | -$1.31M |
|
5182
LiveRamp
RAMP
$2.3B
| $2.29M | ﹤0.01% |
88,527
-155,754
| -64% | -$4.62M |
|
5183
CALL
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.23B
| $2.28M | ﹤0.01% |
55,800
+42,300
| +313% | +$1.8M |
|
|
IBDO
5184
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $2.28M | ﹤0.01% |
+91,025
| New | +$2.29M |
|
|
HZON
5185
PUT
DELISTED
Horizon Acquisition Corporation II
HZON
| $2.28M | ﹤0.01% |
230,500
+175,800
| +321% | +$1.74M |
|
|
MUDS
5186
PUT
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
| $2.28M | ﹤0.01% |
226,500
+100,000
| +79% | +$1.01M |
|
5187
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $2.28M | ﹤0.01% |
36,918
+327
| +0.9% | +$21.6K |
|
5188
PUT
Yelp
YELP
$1.34B
| $2.28M | ﹤0.01% |
82,100
-1,000
| -1% | -$31.1K |
|
5189
CALL
3D Systems Corp
DDD
$616M
| $2.27M | ﹤0.01% |
234,400
-72,400
| -24% | -$845K |
|
5190
Precision BioSciences
DTIL
$205M
| $2.27M | ﹤0.01% |
47,383
+34,198
| +259% | +$2.01M |
|
5191
PUT
Gaming and Leisure Properties
GLPI
$12.7B
| $2.27M | ﹤0.01% |
49,600
+22,300
| +82% | +$1.02M |
|
|
ACH
5192
CALL
Accendra Health
ACH
$73.1M
| $2.27M | ﹤0.01% |
72,300
+1,400
| +2% | +$50.7K |
|
5193
Genesis Energy
GEL
$1.93B
| $2.27M | ﹤0.01% |
283,452
+217,326
| +329% | +$2.45M |
|
5194
CALL
Rambus
RMBS
$10.9B
| $2.27M | ﹤0.01% |
105,700
-30,100
| -22% | -$744K |
|
|
VGR
5195
DELISTED
Vector Group Ltd.
VGR
| $2.27M | ﹤0.01% |
216,150
-276,277
| -56% | -$3.32M |
|
5196
Designer Brands
DBI
$299M
| $2.27M | ﹤0.01% |
173,734
-88,865
| -34% | -$1.28M |
|
5197
CALL
Alector
ALEC
$219M
| $2.27M | ﹤0.01% |
223,000
+130,800
| +142% | +$1.3M |
|
5198
PUT
Avery Dennison
AVY
$13.6B
| $2.27M | ﹤0.01% |
14,000
-900
| -6% | -$154K |
|
5199
JPMorgan US Quality Factor ETF
JQUA
$8.63B
| $2.26M | ﹤0.01% |
+60,796
| New | +$2.41M |
|
5200
Saba Closed-End Funds ETF
CEFS
$444M
| $2.26M | ﹤0.01% |
+131,375
| New | +$2.42M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.